- Author
-
Workplace
4th Department of Internal Medicine Haematol... 1 Cologne Cluster of Excellence in Cellular St... 1 Department 1 of Internal Medicine University... 1 Department of Internal Medicine 3 Ulm Univer... 1 Department of Oncogeriatrics St Marien Hospi... 1 Oncology Practice Erlangen Germany 1 Oncology Practice Leer Germany 1 The Ernest and Helen Scott Haematological Re... 1
- Publication type
- Category
- Language
- Country
- Journal/source
- Most cited
Most cited article - PubMed ID 37279408
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
Journal of clinical oncology.
2023 Jul 20 ;
41 (21) :
3689-3699.
[epub] 20230606
Blood advances.
2025 May 27 ;
9 (10) :
2431-2435.
E-resources
Online
Full text
PubMed
40101233
PubMed Central
PMC12142505
DOI
10.1182/bloodadvances.2024014875
PII: 536217
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Refine by MeSH
V - Publication Characteristics
Top
Cite
Document title
Medvik ISO 690Citace.com
Loading reference ...
Share
Document title
The link will be redirected to the address of the production version after the testing phase.